Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20062
20161
20191
20211
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
AstraZeneca1
Bayer1
Children's Oncology Group1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
Incyte Corporation1
Merck Sharp & Dohme LLC1
Millennium Pharmaceuticals, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms13
Biliary Tract Neoplasms3
Colorectal Neoplasms3
Stomach Neoplasms3
Endometrial Neoplasms2
Pancreatic Neoplasms2
Sarcoma2
Testicular Neoplasms2
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.